- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/22 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors
Patent holdings for IPC class C07K 16/22
Total number of patents in this class: 3877
10-year publication summary
|
322
|
375
|
327
|
341
|
340
|
404
|
349
|
317
|
283
|
28
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4002 |
234 |
| Genentech, Inc. | 3874 |
156 |
| F. Hoffmann-La Roche AG | 7951 |
115 |
| Hoffmann-La Roche Inc. | 3277 |
104 |
| Novartis AG | 11257 |
91 |
| Amgen Inc. | 3902 |
74 |
| Scholar Rock, Inc. | 108 |
69 |
| Mayo Foundation for Medical Education and Research | 3124 |
54 |
| Genzyme Corporation | 1212 |
52 |
| Zoetis Services LLC | 1556 |
43 |
| The Regents of the University of California | 19544 |
42 |
| Boehringer Ingelheim International GmbH | 4750 |
41 |
| Acceleron Pharma Inc. | 373 |
36 |
| Chugai Seiyaku Kabushiki Kaisha | 1319 |
33 |
| Xencor, Inc. | 395 |
29 |
| Abbvie Inc. | 1784 |
27 |
| Eli Lilly and Company | 3726 |
27 |
| MedImmune Limited | 622 |
26 |
| Samsung Electronics Co., Ltd. | 139302 |
24 |
| Pfizer Inc. | 3363 |
22 |
| Other owners | 2578 |